|
|
Other links at Articles > HIV/AIDS |
| 5. |
Tenofovir-Based HIV Postexposure Prophylaxis Promising
|
|
|
Use of once-daily tenofovir DF along with lamivudine or emtricitabine may be more effective than previous regimens for non-occupational postexposure prophylaxis (NPEP) in people at high risk for HIV infection, investigators report in the April 1st issue of the Journal of Acquired Immune Deficiency Syndromes. Reuters Health Information
|
|
|